Oppenheimer Reiterates Teva Pharma (TEVA) at Perform, Notes Progress and Improvements Despite the Miss on Numbers
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell reiterated a Perform rating on Teva Pharma (NYSE: TEVA), following the company's most recent quarterly report ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
